skip to Main Content

Wrong Inventor Defense Fails in Pharmaceutical Litigation

Addressing derivation and obviousness issues, the US Court of Appeals for the Federal Circuit affirmed the district court’s denial of a generic drug…
Go to Source
Author: McDermott Will & Emery

Back To Top